Shared decision-making between doctors and patients can reduce antibiotic use

A training tool that helps physicians involve patients in decision-making can reduce the use of antibiotics for acute respiratory infections, according to a study published in CMAJ (Canadian Medical Association Journal).

Antibiotics are prescribed too often for acute respiratory infections, even though many are not bacterial infections and therefore will not respond to antibiotic use. is a health concern and may be contributing to .

Researchers conducted a cluster randomized trial to determine the impact of a shared decision-making training program called DECISION+2 on the . Shared decision-making, in which a health care professional and patient make a decision together based on evidence and patient preferences, has been shown to be effective when benefits of treatment are not clearly evident for all patients.

The study was divided into two groups, one group of 181 patients who consulted 77 physicians in 5 family practice teaching units using DECISION+2 and a control group of 178 patients who consulted 72 physicians in 4 family practice teaching units. DECISION+2 included an online tutorial followed by an interactive workshop.

"After the intervention, patients in the DECISION+2 group were significantly less likely than patients in the control group to report a decision to use antibiotics immediately after consultation," writes Dr. France Légaré, Research Centre of Centre Hospitalier Universitaire de Québec and Department of Family Medicine and Emergency Medicine, Universitaire Laval, Québec, with coauthors. "The reduction in decisions to use antibiotics was observed in all intervention teaching units, while an increase was seen in 3 of 4 teaching units in the control group."

The results of this study are similar to those from an earlier pilot study that looked at the feasibility of this larger trial.

"These studies indicate that a combination of live and media education are generally effective in changing physician performance in the context of for ," write the authors. "These findings are important given the debate and widespread skepticism about the effect of medical education on the performance of physicians in the practice setting."

More information: Study online: www.cmaj.ca/lookup/doi/10.1503/cmaj.120568

add to favorites email to friend print save as pdf

Related Stories

Study hints at antibiotic overuse in home-care patients

Jun 15, 2011

A study of Canadian home-care patients suggests doctors may be overprescribing antibiotics for patients receiving ongoing medical care at home. The study, published in the June issue of Infection Control and Hospital Epidemiology, the jo ...

Treating acute coughs

Mar 24, 2011

(PhysOrg.com) -- Prescribing antibiotics for patients with discoloured phlegm caused by acute cough has little or no effect on alleviating symptoms and recovery, a new University study has found.

Antibiotics often the wrong prescription for pediatric asthma

Jun 01, 2011

(Medical Xpress) -- At nearly one in six pediatric asthma visits, antibiotics are prescribed as a remedy, despite national guidelines against the practice. Ian Paul, departments of pediatrics and public health sciences, Penn ...

Recommended for you

Determine patient preferences by means of conjoint analysis

13 hours ago

The Conjoint Analysis (CA) method is in principle suitable to find out which preferences patients have regarding treatment goals. However, to widely use it in health economic evaluations, some (primarily methodological) issues ...

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

User comments